Cold-induced urticarial autoinflammatory syndrome related to factor XII activation.
Adult
Blood Coagulation
Bradykinin
/ analogs & derivatives
Cold Temperature
/ adverse effects
Factor XII
/ genetics
Female
HEK293 Cells
Hereditary Autoinflammatory Diseases
/ genetics
Humans
Inflammation Mediators
Interleukin 1 Receptor Antagonist Protein
/ therapeutic use
Interleukin-1beta
/ metabolism
Kininogen, High-Molecular-Weight
/ metabolism
Male
Middle Aged
Mutation
NLR Family, Pyrin Domain-Containing 3 Protein
/ metabolism
Neutrophils
Pedigree
Phenotype
Plasma Kallikrein
/ metabolism
Recombinant Proteins
Skin
/ pathology
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
10 01 2020
10 01 2020
Historique:
received:
13
03
2019
accepted:
05
12
2019
entrez:
12
1
2020
pubmed:
12
1
2020
medline:
3
4
2020
Statut:
epublish
Résumé
Hereditary autoinflammatory diseases are caused by gene mutations of the innate immune pathway, e.g. nucleotide receptor protein 3 (NLRP3). Here, we report a four-generation family with cold-induced urticarial rash, arthralgia, chills, headache and malaise associated with an autosomal-dominant inheritance. Genetic studies identify a substitution mutation in gene F12 (T859A, resulting in p.W268R) which encodes coagulation factor XII (FXII). Functional analysis reveals enhanced autocatalytic cleavage of the mutated protein and spontaneous FXII activation in patient plasma and in supernatant of transfected HEK293 cells expressing recombinant W268R-mutated proteins. Furthermore, we observe reduced plasma prekallikrein, cleaved high molecular weight kininogen and elevated plasma bradykinin. Neutrophils are identified as a local source of FXII. Interleukin-1β (IL-1β) is upregulated in lesional skin and mononuclear donor cells exposed to recombinant mutant proteins. Treatment with icatibant (bradykinin-B2-antagonist) or anakinra (interleukin-1-antagonist) reduces disease activity in patients. In conclusion, our findings provide a link between contact system activation and cytokine-mediated inflammation.
Identifiants
pubmed: 31924766
doi: 10.1038/s41467-019-13984-8
pii: 10.1038/s41467-019-13984-8
pmc: PMC6954242
doi:
Substances chimiques
IL1B protein, human
0
Inflammation Mediators
0
Interleukin 1 Receptor Antagonist Protein
0
Interleukin-1beta
0
Kininogen, High-Molecular-Weight
0
NLR Family, Pyrin Domain-Containing 3 Protein
0
NLRP3 protein, human
0
Recombinant Proteins
0
icatibant
7PG89G35Q7
Factor XII
9001-30-3
Plasma Kallikrein
EC 3.4.21.34
Bradykinin
S8TIM42R2W
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
179Références
Nat Genet. 2014 Oct;46(10):1140-6
pubmed: 25217959
J Immunol. 1995 Aug 1;155(3):1428-33
pubmed: 7636208
Arthritis Rheum. 2011 Nov;63(11):3625-32
pubmed: 21702021
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt B):2118-2127
pubmed: 28743596
J Clin Invest. 2015 Aug 3;125(8):3132-46
pubmed: 26193639
Front Immunol. 2017 Apr 04;8:345
pubmed: 28421072
Immunity. 2011 Feb 25;34(2):258-68
pubmed: 21349432
Blood. 2017 Mar 16;129(11):1527-1537
pubmed: 28069606
J Biol Chem. 2012 Aug 17;287(34):28435-44
pubmed: 22761438
Blood. 2012 Nov 22;120(22):4296-303
pubmed: 22993391
J Leukoc Biol. 1994 Nov;56(5):559-64
pubmed: 7964163
J Clin Invest. 1983 Nov;72(5):1672-7
pubmed: 6556194
Arthritis Rheum. 2011 Mar;63(3):830-9
pubmed: 21360512
J Immunol. 2004 Feb 1;172(3):1839-47
pubmed: 14734768
Eur J Biochem. 1996 May 15;238(1):240-9
pubmed: 8665943
Thromb Haemost. 2013 Sep;110(3):458-68
pubmed: 23349032
Ann Rheum Dis. 2015 Mar;74(3):603-10
pubmed: 24326009
Blood. 2019 Mar 7;133(10):1152-1163
pubmed: 30591525
Immunopharmacology. 1999 Sep;43(2-3):235-9
pubmed: 10596858
J Allergy Clin Immunol. 2016 Nov;138(5):1414-1423.e9
pubmed: 27130860
Blood. 1995 Dec 1;86(11):4134-43
pubmed: 7492770
Clin Genet. 2015 Nov;88(5):441-9
pubmed: 25441681
Blood. 1997 Nov 15;90(10):3967-77
pubmed: 9354665
FEBS Lett. 1989 Apr 24;247(2):189-92
pubmed: 2541011
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Nat Commun. 2020 Jan 10;11(1):179
pubmed: 31924766
J Vasc Res. 2001 Jul-Aug;38(4):370-8
pubmed: 11455208
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Med Prog Technol. 1989;15(1-2):53-62
pubmed: 2530427
Am J Hum Genet. 2006 Dec;79(6):1098-104
pubmed: 17186468
Cytokine. 1996 Feb;8(2):168-77
pubmed: 8777276
J Exp Med. 2009 May 11;206(5):1037-46
pubmed: 19364881
J Clin Invest. 2018 Mar 1;128(3):944-959
pubmed: 29376892
Biochem Pharmacol. 1989 Mar 15;38(6):993-1000
pubmed: 2539165
Nat Genet. 2001 Nov;29(3):301-5
pubmed: 11687797
Nat Genet. 2014 Oct;46(10):1135-1139
pubmed: 25217960
Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1614-9
pubmed: 18230725
Hum Genet. 2017 Jun;136(6):665-677
pubmed: 28349240
Ann Rheum Dis. 2012 Jul;71(7):1177-82
pubmed: 22377804
J Biol Chem. 1994 Jul 29;269(30):19307-12
pubmed: 8034694
Br J Dermatol. 2018 Feb;178(2):561-562
pubmed: 28580686
Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11969-72
pubmed: 1465426
J Allergy Clin Immunol. 2017 Jul;140(1):170-176
pubmed: 27826093
Rheumatology (Oxford). 2014 Jul;53(7):1301-6
pubmed: 24599920
Mediators Inflamm. 2016;2016:4567343
pubmed: 27721576
J Allergy Clin Immunol. 2017 Dec;140(6):1700-1703.e8
pubmed: 28782632
Curr Med Res Opin. 2008 Sep;24(9):2531-43
pubmed: 18667113
J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1209-1216.e8
pubmed: 29128335
N Engl J Med. 2012 Jan 26;366(4):330-8
pubmed: 22236196